UoG Sociology Café

Global Vaccine Inequity

Resource page

Links and material that circulated during the session

Vaccine_inequity.pptx

Covid-19: AstraZeneca vaccine is not linked to increased risk of blood clots, finds European Medicine AgencyThe Oxford-AstraZeneca covid-19 vaccine is not linked to an increased risk of blood clots and is both safe and effective, an investigation by the European Medicine Agency (EMA) has concluded.1 The in-depth analysis of evidence—including laboratory results, clinical reports, autopsies, and clinical trial data—was carried out after a small number of blood clot cases (37) were reported in people who had received the vaccine. This led to 16 EU countries halting their vaccine rollout.2 “The committee has come to a clear scientific conclusion. This is a safe and effective vaccine,” said Emer Cooke, EMA executive director, at a press conference on 18 March. “Its benefits in protecting people from covid-19 with the associated risks of death and hospitalisation outweigh the possible risks. The committee also concluded that the vaccine is not associated with an increase in the overall risk of thromboembolic events or blood clots.” Sabine Straus, chair of the Pharmacovigilance Risk …

Coronavirus (COVID-19) Vaccinations - Statistics and ResearchOur vaccination dataset uses the most recent official numbers from governments and health ministries worldwide. Population estimates for per-capita metrics are based on the United Nations World Population Prospects. Income groups are based on the World Bank classification. A full list of our country-specific sources is available at the bottom of this page, and we also answer frequently-asked questions there.

The necropolitics of COVID-19: Race, class and slow death in an ongoing pandemic - PubMedAchille Mbembe states that 'the ultimate expression of sovereignty resides, to a large degree, in the power and the capacity to dictate who may live and who must die […]. To exercise sovereignty is to exercise control over mortality and to define life as the deployment and manifestation of power' (M …

Vaccine Access - UNDP Covid-19 Data Futures PlatformA slower and delayed vaccination rollout in low and middle-income countries has left them vulnerable to COVID-19 variants, new surges of the virus and a slower recovery out of the crisis. High-income countries started vaccination on average two months earlier than low-income countries and access to vaccines in low-income countries is still strikingly low.

Page updated

Google Sites

Report abuse